📌 What’s New in Diabetes Management – 2025 ADA Guideline?

Dear Doctors, Now, it is time to kindly present the academic insights of Dr. Kyar Nyo Soe Myint on:

✅ “Comprehensive Medical Evaluation and Assessment of Comorbidities” • Metabolic-Associated Steatotic Liver Disease (MASLD) • Metabolic-Associated Steatohepatitis (MASH)

✅ “Children and Adolescents” and

✅ “Older Adults” 📌 This program is organized by the Myanmar Diabetes Association (MMDA) and the Myanmar Society of Endocrinology and Metabolism (MSEM).

💊This program is proudly supported by Ziglip 50 & 100 (Sitagliptin 50 mg & 100 mg) and Emflozin 10 & 25 (Empagliflozin 10 mg & 25 mg).

#ADA #StandardsofCare #ADAguideline #Recommendations #Diabetes #Hyperglycemia #Obesity #WeightManagement #MASLD #MASH #CardiovascularDisease #GlycemicGoals #Renal #MSEM #MMDA #Ziglip #Sitagliptin #Emflozin #Empagliflozin #Zifam #CaringForWellbeing